Resources for You
Inhibitor development is the most severe treatment challenge that can affect anyone with hemophilia A at any time.1,2 Utilize the resources on this page to learn how the results from the SIPPET study may affect you.
VIDEO STORIES
Learn more about inhibitors and SIPPET from leading hematologists.
Dr. Flora Peyvandi
Hematologist, Italy
Dr. Steve Austin
Hematologist, United Kingdom
Dr. Angelika Batorova
Hematologist, Slovakia
HELPFUL LINKS
You aren't alone. Currently, there are an estimated 400.000 people living with hemophilia worldwide.3 Find more information and support from established and well-known advocates within the hemophilia community.
World Federation of Hemophilia
A global network of healthcare providers, national hemophilia associations, people with hemophilia, and their families.
European Hemophilia Consortium
An international non-profit organization that represents 45 national patients' organizations of people with rare bleeding disorders from 27 Member States of the European Union (EU) and most Member States of the Council of Europe.
National Hemophilia Foundation
Dedicated to finding better treatments and cures for inheritable bleeding disorders.
Hope for Hemophilia
Established to help give hope, strength, and resources to people living with hemophilia and their families.
REFERENCES
- Srivastava A, Brewer AK, Mauser-Bunschonten EP, et al; Treatment Guidelines Working Group. Guidelines for the Management of Hemophilia. 2nd Ed. Montreal, Canada: World Federation of Hemophilia; 2012.
- Hay CR e.t al. Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. Blood. 2011; 117(23):6367-6370.
- Hemophilia Federation of America. What is hemophilia? Hemophilia Federation of America website. http://hemophiliafed.org/bleeding-disorders/hemophilia/. Accessed June 16, 2016.